Metadata Framework to Support Deployment of Digital Health Technologies in Clinical Trials in Parkinson's Disease.Hill DL, Stephenson D, Brayanov J, Claes K, Badawy R, Sardar S, Fisher K, Lee SJ, Bannon A, Roussos G, Kangarloo T, Terebaite V, Müller MLTM, Bhatnagar R, Adams JL, Dorsey ER, Cosman J. Sensors (Basel). 2022 Mar 9;22(6):2136. doi: 10.3390/s22062136. PMID: 35336307; PMCID: PMC8954603.
Precompetitive Consensus Building to Facilitate the Use of Digital Health Technologies to Support Parkinson Disease Drug Development through Regulatory Science.Stephenson D, Alexander R, Aggarwal V, Badawy R, Bain L, Bhatnagar R, Bloem BR, Boroojerdi B, Burton J, Cedarbaum JM, Cosman J, Dexter DT, Dockendorf M, Dorsey ER, Dowling AV, Evers LJW, Fisher K, Frasier M, Garcia-Gancedo L, Goldsack JC, Hill D, Hitchcock J, Hu MT, Lawton MP, Lee SJ, Lindemann M, Marek K, Mehrotra N, Meinders MJ, Minchik M, Oliva L, Romero K, Roussos G, Rubens R, Sadar S, Scheeren J, Sengoku E, Simuni T, Stebbins G, Taylor KI, Yang B, Zach N. Digit Biomark. 2020 Nov 26;4(Suppl 1):28-49. doi: 10.1159/000512500. Erratum in: Digit Biomark. 2021 Nov 25;5(3):224. PMID: 33442579; PMCID: PMC7768153.
Identifying and Characterising Sources of Variability in Digital Outcome Measures in Parkinson’s Disease. Roussos G, Ruiz Herrero T, Hill D, Dowling A, Muller M, Evers L, Burton J, Derungs A, Fisher K, Praneeth Kilambi K, Mehrotra N, Bhatnagar R, Sardar S, Stephenson D, Adams J, Dorsey E, Cosman J. Nature Digital Medicine 2022 (in press)
Abstracts
Cybersecurity in connected medical devices. Derek Hill, Alizee Devaux, Jeremy Roche (PDH), Roain Jayles, T Franco Rondisson (CEA), I Chartier IRT Nanoelec. ADTC 2022 Dresden.
A Reference Architecture Proposal for Secure Data Management in Mobile Health. Angelelli M, Catalano C, Hill D, Koshutanski H, Pascarelli C, Rafferty J. IEEE Comsoc 7thInternational Conference on Smart and Sustainable Technologies: Splittech 2022.
Mueller, M., Cosman, J., Adams, J. L., Badawy, R., Bhatnagar, R., Bloem, B., . . . Stephenson, D. (2022). Interaction with Regulatory Agencies Worldwide to Advance the Use of Digital Health Technology in Parkinson's Disease Clinical Research: the Critical Path for Parkinson's Pre-Competitive 3DT Initiative.
OPTIMIZING PATHS FOR EFFICIENT USE OF DIGITAL HEALTH TECHNOLOGIES IN PD CLINICAL TRIALS: THE CRITICAL PATH FOR PARKINSON’S 3DT INITIATIVE. Derek Hill 1, Martijn Müller 2, Jesse Cedarbaum3 , Josh Cosman4 , Lauren Oliva5 , Mark Frasier6 , Marissa Dockendorf 7 , Ariel Dowling8 , Kirsten Taylor 9 , Emily Kunka10, Caldeira Caldeira11, Ray Dorsey12, Diane Stephenson2 (1. University College Of London - London (France), 2. Critical Path Institute - Tucson (United States), 3. Coeruleus Clinical Sciences - Woodbridge (United States), 4. Abbvie - Cambridge (United States), 5. Biogen - Cambridge (United States), 6. The Michael J. Fox Foundation - New York (United States), 7. Merck - Philadelphia (United States), 8. Takeda - Social Circle (United States), 9. Roche - Basel (Switzerland), 10. Ucb - San Francisco (United States), 11. Lundbeck - Copenhagan (Denmark), 12. University Of Rochester - Rochester (United States)) J prev Alz Disease 4/2021 P65
P66- REDUCING SOURCES OF VARIABILITY OF DIGITAL HEALTH TECHNOLOGIES IN CLINICAL TRIALS BY ADDING ENVIRONMENTAL CONTEXT. Derek Hill, Tri Thanh Tam Tran, Nicolas Defranoux, Alizee Devaux, Souleyme n Sahnoun (Panoramic Digital Health - Grenoble (France)). J prev Alz Disease 4/2021 P65 P66
Stephenson, D., Akalu, M., Alexander, R., Bloem, B., Boroojerdi, B., Bravi, D., . . . Dexter, D. (2019). Critical Path for Parkinson's: Catalyzing Innovation for Parkinson's Clinical Trials through Data Sharing and Regulatory Science. Presented at: 71st Annual Meeting of the American-Academy-of-Neurology (AAN).
